Amandine Cournil

Origin of the HIV-1 group O epidemic in western lowland gorillas

Mirela D’arc, Ahidjo Ayouba, Amandine Esteban et al. · Proceedings of the National Academy of Sciences · 2015 · 187 citations · Full text

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack et al. · The Lancet HIV · 2020 · 155 citations

Open Label, Week 96, Treatment And Prevention +10

Handgrip Strength Among Nonagenarians and Centenarians in Three European Regions

Bernard Le Jeune, Axel Skytthe, Amandine Cournil et al. · The Journals of Gerontology Series A · 2006 · 102 citations · Full text

Human Antibody Response to Aedes aegypti Saliva in an Urban Population in Bolivia: A New Biomarker of Exposure to Dengue Vector Bites

Souleymane Doucouré, François Mouchet, Amandine Cournil et al. · American Journal of Tropical Medicine and Hygiene · 2012 · 72 citations · Full text

Entomology, Malaria, Dengue Vector Bites +16

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo et al. · The Lancet HIV · 2017 · 71 citations

Lamivudine Dual Therapy, Superiority Trial, Protease Inhibitor +9